Presentation Information

[27-16-pm11S]Efficient knock-down of target genes by using a CRISPR-Cas13 system-expressing adenovirus vector in vitro and in vivo.

○Yuki Osakada1, Sota Kidawara2, Eiko Sakai1, Akira Asayama1, Kahori Shimizu1,2, Fuminori Sakurai3, Hiroyuki Mizuguchi1,2,4,5,6,7 (1. Graduate School of Pharmaceutical Sciences, Osaka University., 2. School of Pharmaceutical Sciences, Osaka University., 3. Department of Pharmacy, Kindai Universiry., 4. National Institute of Biomedical Innovation, Health and Nutrition., 5. Global Center for Medical Engineering and Informatics, Osaka University., 6. Institute for Open and Transdisciplinary Research Initiatives, Osaka University., 7. Center for Infectious Disease Education and Research, Osaka University.)